Welcome to The Briefing: Register or log in to tailor our content to your needs

The Briefing is all about showing you what you're most interested in. Personalize the content on The Briefing by choosing exactly what you want to see.

Subject Relevance
Sections

UCL INSTITUTE OF BIOMEDICAL ENGINEERING

In-Vitro Diagnostics

1 - 10 of 434 items

What the EU’s proposed IVD regulation means for you

 

The proposed in vitro diagnostic (IVD) device regulation is substantially different from the current directive, and includes revised classification rules and evaluation requirements. And the sheer volume of the proposed amendments—a total of 194 pages, including 97 articles and… Read more →

New mHealth device aims to give clinical capability to consumers

 

A San Diego startup wants to disrupt self tracking and healthcare delivery with a lab-grade mHealth consumer device. The consumerization of healthcare, together with the ever-increasing need to know more about our bodies, has given rise to the likes… Read more →

Diabetes diagnosed with inexpensive, portable microchip test

As childhood obesity rates rise, so do rates of type 2 diabetes in children.

Coupled with the rise in type 1 diabetes in adults, it is becoming increasingly difficult to

differentiate the two diseases without resorting to a slow, expensive… Read more →

New test predicts survival and disease progression in blood cancer patients

Scientists have developed a test which accurately predicts the prognosis for patients with the most common form of leukaemia.

The findings could also inform the development of a prognostic test for patients with other forms of cancer.

Researchers from Cardiff… Read more →

RD Biomed announces Chinese distribution agreement for reflux diagnostic tool Peptest

RD Biomed, the Yorkshire medical technology company, has announced a Chinese distribution agreement for its world-leading reflux diagnostic tool Peptest.

The deal with Hong Kong-based investment and trading company MAAB International will see Peptest launched in China by 2016. Peptest… Read more →

Designing ultra-sensitive biosensors for early personalised diagnostics

A new type of high-sensitivity and low-cost sensors, called plasmonic biosensors, could ultimately become a key asset in personalised medicine by helping to diagnose diseases at an early stage.

Personalised medicine is one of the new developments that is deemed… Read more →

Blood test for breast cancer comes step closer

 

A woman may be able to have a simple blood test in the future to find out if she could develop breast cancer, British researchers say.

The test is in development after new research uncovered a genetic “early marker”… Read more →

ONCOblot test identifies ENOX2 cancer marker, paves way for minimally invasive tests

Cancer is rarely black and white, and it’s no small matter no matter how small, but a new discovery in the field of cancer screenings has come to light that signals a shift to an earlier, more certain and specific… Read more →

Fast, portable device for “on-the-go” cocaine testing

Testing for cocaine and other drugs usually involves two steps: a quick on-site prescreen, and then a more accurate confirmatory test at a distant laboratory. This process can take days or weeks—but that’s too long in many cases where public… Read more →

China FDA approves Bruker MALDI-TOF system for use as a medical device

Bruker (Beijing, China) has received clearance from the China Food and Drug Administration (CFDA; also in Beijing) to market and sell its in vitro diagnostic (IVD) MALDI Biotyper system as a medical device in China for identifying microorganisms isolated from human specimens.

Read more →

Cookies on IBME website

Our website uses cookies to provide us with important information about visitors. By continuing to browse the site we'll assume that you are happy to receive all cookies set by IBME.